Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 7.99
- Piotroski Score 7.00
- Grade Overweight
- Symbol (ZTS)
- Company Zoetis Inc.
- Price $174.28
- Changes Percentage (2.29%)
- Change $3.91
- Day Low $169.64
- Day High $174.79
- Year High $201.92
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
- Last Earnings 10/10/2024
- Ex-Dividend for 5/16 Dividend 10/31/2024
- Dividend Payable 12/03/2024
- Today N/A
- Next Earnings (Estimated) 02/11/2025
- Fiscal Year End N/A
- Average Stock Price Target $230.00
- High Stock Price Target $254.00
- Low Stock Price Target $195.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $5.20
- Trailing P/E Ratio 34.02
- Forward P/E Ratio 34.02
- P/E Growth 34.02
- Net Income $2.34 B
Income Statement
Quarterly
Annual
Latest News of ZTS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Decoding Zoetis Inc (ZTS): A Strategic SWOT Insight
Zoetis Inc, a key player in animal health, showcases strong financial performance with revenue and net income growth. The company's market leadership, diversified portfolio, and strategic acquisitions...
By Yahoo! Finance | 2 days ago -
Zoetis (NYSE:ZTS) Declares $0.432 Dividend and Unveils Innovative Vetscan OptiCell for Market Growth
Zoetis is launching the AI-powered Vetscan OptiCell™ to improve veterinary care efficiency and has declared a stable dividend. Despite challenges like a slight profit margin dip and high debt levels...
By Yahoo! Finance | 5 days ago -
Jim Cramer Likes Zoetis Inc (NYSE:ZTS) "Very Much"
The list of Jim Cramer's top stock picks for Q4 includes Zoetis Inc (NYSE:ZTS), ranking 4th. Cramer advises investors to capitalize on short-term rallies and take profits when stocks rise....
By Yahoo! Finance | 1 month ago
